On December 17th 2024 Massimo Mastrangeli (TU Delft) has been appointed as the new vice-chair of the hDMT Consortium Assembly. With his technology-oriented profile and expertise he complements the stem cell expertise of Vivi Heine (Amsterdam UMC), who is the current chair of the Consortium Assembly. Together they will contribute to the further growth and development of hDMT.
Role within hDMT
Since he joined TU Delft in 2017, Massimo has been in close contact with hDMT and many of its contributing partners, starting with his direct involvement in the ‘ORCHID’ European project, and later by virtue of the research work of his group in electromechanical OoC devices – embedded within several national programs and projects such as the ‘NOCI’ (Netherlands Organ-on-Chip Initiative), ‘LymphChip’, ‘Smart OoC’, ‘Convergence Flagship’ projects between TU Delft and Erasmus MC, and NXTGEN Hightech’s Biomed03 (Organ-on-Chip) – and more recently as chair of hDMT’s Brain-on-Chip theme group. Along with his direct expertise in materials and fabrication technologies for Organ-on-Chip devices and platforms, Massimo has an extensive network of collaborations with many national and international partners, both academic and industrial, resulting in his familiarity with the national and international OoC scenarios, their trends and perspectives, their challenges and opportunities. As vice-chair of the hDMT Consortium Assembly Massimo will contribute to steering discussion and coordinating contributions among partners, and helping shape the view on the future of OoC technology.
Bio sketch
Massimo Mastrangeli is Associate Professor in the Electronic Components, Technology and Materials (ECTM) section of the Microelectronics department of Delft University of Technology (Delft, The Netherlands), where he is developing innovative microelectromechanical organ-on-chip devices and platforms.
He got his BSc and MSc degrees cum laude in electronic engineering from University of Pisa (IT), and his PhD degree in materials engineering from University of Leuven (BE). Massimo held research positions at imec (Leuven, BE), École Polytechnique Fédérale de Lausanne (EPFL, CH), Université Libre de Bruxelles (BE) and Max Planck Institute for Intelligent Systems (Stuttgart, DE).
The research of his group at TU Delft has contributed to several national and European projects. Massimo has in particular led the second workpackage of the European KDT-JU “Moore4Medical” project, focused on the development and qualification of open technology platforms for organs-on-chip, and is presently leading the national multi-partner NXTGEN Hightech’s “Biomedical Production Technology 3 – organ-on-chip” project to further advance OoC platforms and bring them to commercial availability.
Massimo is currently also Guest Lecturer at EPFL and Board Member of the European Organ-on-Chip Society (EUROoCS).
